Prothena Corp Public Ltd Co (PRTA) — 8-K Filings

8-K Filings (19)

• 8-K Filing — May 7, 2026
• Prothena Appoints New CMO, Dr. Cox Departs — Dec 12, 2025 Risk: medium
  Prothena Corporation plc announced on December 10, 2025, the departure of Dr. Genevieve L. Cox from her role as Chief Medical Officer. Concurrently, the company
• Prothena Corp Files 8-K: Security Holder Vote & Exhibits — Nov 19, 2025 Risk: low
  On November 19, 2025, Prothena Corporation plc filed an 8-K report. The filing indicates that the company is submitting matters to a vote of its security holder
• Prothena Corp files 8-K on Financials — Nov 6, 2025 Risk: low
  On November 6, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, al
• Prothena Corp Files 8-K: Other Events & Financials — Aug 27, 2025 Risk: low
  On August 27, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicati
• Prothena Corp Files 8-K: Other Events & Exhibits — Aug 6, 2025 Risk: low
  On August 6, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specif
• Prothena Corp Files 8-K: Board & Executive Changes — Jul 30, 2025 Risk: low
  On July 30, 2025, Prothena Corporation plc filed an 8-K report detailing changes in its board of directors and executive officers, as well as updates to its com
• Prothena Corp Appoints New Officers, Director Departs — Jun 18, 2025 Risk: medium
  On June 13, 2025, Prothena Corporation plc reported a departure of a director, Dr. Jeffrey M. Stein, effective June 13, 2025. The company also announced the app
• Prothena Corp Files 8-K Report — Jun 16, 2025 Risk: low
  On June 15, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns other events and financial statements and exhibits. No specific ma
• Prothena Corp Files 8-K: Other Events & Financials — May 23, 2025 Risk: low
  On May 23, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no spe
• Prothena Corp Adds Director, Files 8-K — May 16, 2025 Risk: low
  Prothena Corporation plc announced on May 13, 2025, the election of Dr. Genevieve Nelson to its Board of Directors, effective immediately. Dr. Nelson brings ext
• Prothena Corp Files 8-K on Financials — Feb 20, 2025 Risk: low
  On February 20, 2025, Prothena Corporation plc filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, a
• Prothena Corp Appoints New Director, Reports Executive Compensation — Dec 30, 2024 Risk: low
  On December 29, 2024, Prothena Corporation plc announced changes to its Board of Directors. Dr. Tracey L. Weiler has been appointed as a new director, effective
• Prothena Appoints New Chief Medical and Development Officers — Sep 27, 2024 Risk: medium
  On September 23, 2024, Prothena Corporation plc announced the appointment of Dr. Amina Khan as Chief Medical Officer and Dr. Jonathan Venner as Chief Developmen
• Prothena Strikes $1.26B ALS Deal with Novo Nordisk — May 28, 2024 Risk: medium
  On May 24, 2024, Prothena Corporation plc entered into a material definitive agreement, specifically a collaboration and license agreement with Novo Nordisk A/S
• Prothena Corp plc Annual Meeting Results Approved — May 17, 2024 Risk: low
  On May 14, 2024, Prothena Corporation plc announced the results of its Annual General Meeting. Shareholders approved all proposed resolutions, including the re-
• Prothena Reports Officer Changes & Compensation on Feb 21 — Feb 21, 2024 Risk: medium
  Prothena Corporation Public Limited Company filed an 8-K on February 21, 2024, to report on the departure or election of directors or certain officers and compe
• Prothena Files 8-K on Financial Condition and Operations — Feb 15, 2024 Risk: low
  Prothena Corporation Public Limited Company filed an 8-K on February 15, 2024, reporting on its results of operations and financial condition. The filing, with
• Prothena Updates Corporate Address & Contact Info in 8-K Filing — Jan 8, 2024
  Prothena Corporation Public Limited Company filed an 8-K on January 8, 2024, to update its corporate information, specifically its address and contact details.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX